Evidence map›Paper›PMID 31665331›Full record

ArticleGenome biology and evolution2019

Gene Composition as a Potential Barrier to Large Recombinations in the Bacterial Pathogen Klebsiella pneumoniae.

Francesco Comandatore, Davide Sassera, Sion C Bayliss, Erika Scaltriti, Stefano Gaiarsa, Xiaoli Cao, Ana C Gales, Ryoichi Saito, Stefano Pongolini, Sylvain Brisse and 2 more

Open access · goldAbstract read
In one paragraph

Article in Genome biology and evolution, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.8field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 9 institutions in 6 countries.

Francesco ComandatoreSky Net UNIMI Platform - Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, Dipartimento di Scienze Biomediche e Cliniche Luigi Sacco, Università degli Studi di Milano, Italy.
Davide SasseraDepartment of Biology and Biotechnology L. Spallanzani, Universita' degli Studi di Pavia, Italy.
Sion C BaylissMilner Centre for Evolution, Department of Biology and Biochemistry, University of Bath, United Kingdom.
Erika ScaltritiRisk Analysis and Genomic Epidemiology Unit, Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia-Romagna, Parma, Italy.
Stefano GaiarsaU.O.C. Microbiologia e Virologia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Xiaoli CaoDepartment of Laboratory Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, People's Republic of China.
Ana C GalesLaboratório ALERTA, Division of Infectious Diseases, Department of Internal Medicine, Escola Paulista de Medicina - EPM, Universidade Federal de São Paulo (UNIFESP), Brazil.
Ryoichi SaitoDepartment of Molecular Microbiology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
Stefano PongoliniRisk Analysis and Genomic Epidemiology Unit, Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia-Romagna, Parma, Italy.
Sylvain BrisseInstitut Pasteur, Biodiversity and Epidemiology of Bacterial Pathogens, Paris, France.
Edward J FeilMilner Centre for Evolution, Department of Biology and Biochemistry, University of Bath, United Kingdom.
Claudio BandiSky Net UNIMI Platform - Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, Dipartimento di Bioscienze, Università degli Studi di Milano, Italy.
Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna "Bruno Ubertini" · ITUniversity of Bath · GBUniversity of Milan · ITInstitut Pasteur · FRIstituti di Ricovero e Cura a Carattere Scientifico · ITNanjing Drum Tower Hospital · CNTokyo Medical and Dental University · JPUniversidade Federal de São Paulo · BRUniversity of Pavia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Klebsiella pneumoniae (Kp) is one of the most important nosocomial pathogens worldwide, able to cause multiorgan infections and hospital outbreaks. One of the most widely disseminated lineage of Kp is the clonal group 258 (CG258), which includes the highly resistant "high-risk" sequence types ST258 and ST11. Genomic investigations revealed that very large recombination events have occurred during the emergence of Kp lineages. A striking example is provided by ST258, which has undergone a recombination event that replaced over 1 Mb of the genome with DNA from an unrelated Kp donor. Although several examples of this phenomenon have been documented in Kp and other bacterial species, the significance of these very large recombination events for the emergence of either hypervirulent or resistant clones remains unclear. Here, we present an analysis of 834 Kp genomes that provides data on the frequency of these very large recombination events (defined as those involving >100 kb), their distribution within the genome, and the dynamics of gene flow within the Kp population. We note that very large recombination events occur frequently, and in multiple lineages, and that the majority of recombinational exchanges are clustered within two overlapping genomic regions, which have been involved by recombination events with different frequencies. Our results also indicate that certain lineages are more likely to act as donors to CG258. Furthermore, comparison of gene content in CG258 and non-CG258 strains agrees with this pattern, suggesting that the success of a large recombination depends on gene composition in the exchanged genomic portion.

Indexed as

Recombination, GeneticClone CellsGenome, BacterialHumansKlebsiella InfectionsKlebsiella pneumoniaeclonal group 258Klebsiella pneumoniaelarge recombination

Identifiers

PMID31665331
PMCPMC6865855
OpenAlexW2982583142

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.